ArticleJugan geon-gang gwa jilbyeong2024
[Characteristics of Notified Tuberculosis Cases in the Republic of Korea, 2023].
Article in Jugan geon-gang gwa jilbyeong, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Whole-Genome and Targeted Sequencing of 75 Drug-ResistantAnnals of laboratory medicine · 2026Article
- Bridging Genotypic and Phenotypic Drug Susceptibility Testing forAnnals of laboratory medicine · 2026Article
- Performance and Cost-Efficiency of an MPT64 Assay for DetectingJournal of Korean medical science · 2026Article
- Whole-Genome Sequencing and Phenotypic Drug Susceptibility Testing of Bedaquilin, Delamanid, Pretomanid, and Linezolid in Drug-ResistantPathogens (Basel, Switzerland) · 2026Article
- The Tuberculosis Relief Belt Project in the Republic of Korea: A 10-Year Review of Performance and Future Directions (2014-2024).Public health weekly report · 2026Review
- Predictive Factors Associated With Multidrug-Resistant Tuberculosis Among Tuberculosis Patients in Southwest Ethiopia: An Unmatched Case-Control Study.Health science reports · 2025Article
- The impact of population ageing on tuberculosis incidence, mortality, and case fatality in South Korea: a nationwide retrospective study.ERJ open research · 2025Article
- [Development History and Composition of Korea Tuberculosis Network System].Jugan geon-gang gwa jilbyeong · 2025Review
- [The History of Tuberculosis Prevention Day and National Strategic Plan for Tuberculosis Control in Republic of Korea].Jugan geon-gang gwa jilbyeong · 2025Review
- [Tuberculosis Notification Status in the Republic of Korea, 2024].Jugan geon-gang gwa jilbyeong · 2025Article
- [Review of the Global Burden of Tuberculosis in 2023: Insights from the WHO Global Tuberculosis Report 2024].Jugan geon-gang gwa jilbyeong · 2025Article
- [Characteristics and Trends of Tuberculosis Deaths in 2023: An Analysis of Cause-of-death Statistics from Statistics Korea].Jugan geon-gang gwa jilbyeong · 2025Article
- Increased Risk of Tuberculosis Disease in Lung Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy: A Retrospective Multicenter Study.Respiration; international review of thoracic diseases · 2025Article
- Determinants of the lost to follow-up status among patients with tuberculosis who emigrated to the Republic of Korea: a mixed-method study.Frontiers in public health · 2025Article
- Which infectious diseases are currently posing problems in the Republic of Korea? One out of every two tuberculosis patients is over 65 years old.Osong public health and research perspectives · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
43 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In 2023, the total number of notified tuberculosis (TB) cases was 19,540 cases (38.2 cases per 100,000 population), down 4.1% from 2022 (n=20,383, 39.8 cases per 100,000 population). This represents a decrease of 61.3% over 12 consecutive years, with an annual average decrease of 7.6% after reaching the highest level in 2011. In addition, the total number of TB cases for people aged 65 years and older in 2023 was 11,309 cases (119.5 cases per 100,000 population), a 0.1% increase compared to 2022 (n=11,298), and the proportion of TB cases aged 65 years and older was 57.9%. This proportion has been increasing every year since 2000. Furthermore, the total number of foreign TB cases was 1,107 cases, an increase of 3.3% compared to 2022 (n=1,072), and the proportion of foreign TB cases was 5.7%, a slight increase from 2022 (5.3%). In 2023, the number of multidrug-resistant/rifampicin-resistant TB (MDR/RR-TB) cases was 551 and represented a decrease of 1.6% compared to 2022 (n=560), and the proportion of MDR/RR-TB cases among total TB cases was 2.8%. In March 2023, the Korea Disease Control and Prevention Agency (KDCA) established the Third National Strategic Plan for TB Control (2023-2027), which continues TB control projects for TB screening among vulnerable populations, people-centered TB case management, and the operation of a MDR-TB consortium, aiming to decrease the TB incidence rate to less than 20 cases per 100,000 population by 2027.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.